PMID- 23398888 OWN - NLM STAT- MEDLINE DCOM- 20130906 LR - 20231104 IS - 1471-2164 (Electronic) IS - 1471-2164 (Linking) VI - 14 DP - 2013 Feb 11 TI - Combined ChIP-Seq and transcriptome analysis identifies AP-1/JunD as a primary regulator of oxidative stress and IL-1beta synthesis in macrophages. PG - 92 LID - 10.1186/1471-2164-14-92 [doi] AB - BACKGROUND: The oxidative burst is one of the major antimicrobial mechanisms adopted by macrophages. The WKY rat strain is uniquely susceptible to experimentally induced macrophage-dependent crescentic glomerulonephritis (Crgn). We previously identified the AP-1 transcription factor JunD as a determinant of macrophage activation in WKY bone marrow-derived macrophages (BMDMs). JunD is over-expressed in WKY BMDMs and its silencing reduces Fc receptor-mediated oxidative burst in these cells. RESULTS: Here we combined Jund RNA interference with microarray analyses alongside ChIP-sequencing (ChIP-Seq) analyses in WKY BMDMs to investigate JunD-mediated control of macrophage activation in basal and lipopolysaccharide (LPS) stimulated cells. Microarray analysis following Jund silencing showed that Jund activates and represses gene expression with marked differential expression (>3 fold) for genes linked with oxidative stress and IL-1beta expression. These results were complemented by comparing whole genome expression in WKY BMDMs with Jund congenic strain (WKY.LCrgn2) BMDMs which express lower levels of JunD. ChIP-Seq analyses demonstrated that the increased expression of JunD resulted in an increased number of binding events in WKY BMDMs compared to WKY.LCrgn2 BMDMs. Combined ChIP-Seq and microarray analysis revealed a set of primary JunD-targets through which JunD exerts its effect on oxidative stress and IL-1beta synthesis in basal and LPS-stimulated macrophages. CONCLUSIONS: These findings demonstrate how genetically determined levels of a transcription factor affect its binding sites in primary cells and identify JunD as a key regulator of oxidative stress and IL-1beta synthesis in primary macrophages, which may play a role in susceptibility to Crgn. FAU - Hull, Richard P AU - Hull RP AD - MRC Clinical Sciences Centre, Imperial College London, Hammersmithhospital, Du Cane Road W12 0NN, London, UK. FAU - Srivastava, Prashant K AU - Srivastava PK FAU - D'Souza, Zelpha AU - D'Souza Z FAU - Atanur, Santosh S AU - Atanur SS FAU - Mechta-Grigoriou, Fatima AU - Mechta-Grigoriou F FAU - Game, Laurence AU - Game L FAU - Petretto, Enrico AU - Petretto E FAU - Cook, H Terence AU - Cook HT FAU - Aitman, Timothy J AU - Aitman TJ FAU - Behmoaras, Jacques AU - Behmoaras J LA - eng GR - MC_U120097112/MRC_/Medical Research Council/United Kingdom GR - WT092523MA/WT_/Wellcome Trust/United Kingdom GR - 087182/Z/08/Z/WT_/Wellcome Trust/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130211 PL - England TA - BMC Genomics JT - BMC genomics JID - 100965258 RN - 0 (Interleukin-1beta) RN - 0 (JunD protein, rat) RN - 0 (Lipopolysaccharides) RN - 0 (Proto-Oncogene Proteins c-jun) RN - 0 (Transcription Factor AP-1) SB - IM MH - Animals MH - Binding Sites MH - Gene Expression/drug effects MH - Gene Expression Profiling MH - Glomerulonephritis/chemically induced/genetics/metabolism/pathology MH - Interleukin-1beta/biosynthesis/genetics/*metabolism MH - Lipopolysaccharides/toxicity MH - Macrophages/cytology/drug effects/*metabolism MH - Oxidative Stress/*genetics MH - Primary Cell Culture MH - Protein Binding MH - *Proto-Oncogene Proteins c-jun/genetics/metabolism MH - Rats MH - *Transcription Factor AP-1/genetics/metabolism PMC - PMC3608227 EDAT- 2013/02/13 06:00 MHDA- 2013/09/07 06:00 PMCR- 2013/02/11 CRDT- 2013/02/13 06:00 PHST- 2012/10/13 00:00 [received] PHST- 2013/02/01 00:00 [accepted] PHST- 2013/02/13 06:00 [entrez] PHST- 2013/02/13 06:00 [pubmed] PHST- 2013/09/07 06:00 [medline] PHST- 2013/02/11 00:00 [pmc-release] AID - 1471-2164-14-92 [pii] AID - 10.1186/1471-2164-14-92 [doi] PST - epublish SO - BMC Genomics. 2013 Feb 11;14:92. doi: 10.1186/1471-2164-14-92.